Particle Therapy: the next frontier in cancer therapy.

IBA is the undisputed leader in particle therapy, acknowledged to be the most precise and effective clinical radiotherapy method in the selective destruction of cancer cells. To date, more than 25 world renowned medical institutions have built a Particle Therapy Center with IBA.

IBA : opening new ways in the fight against cancer.
IBA is a cancer diagnostics and treatment company and the worldwide technology leader in the field of proton therapy. The Company’s expertise lies in the development of next generation proton therapy technologies and radiopharmaceuticals that provide oncology care providers with premium quality services and equipment, including IBA’s leading fully integrated IntegraLab® radiopharmacy system, and Dosimetry advanced solutions for Quality Assurance of medical equipment and increased patient safety.

Headquartered in Belgium and employing more than 1,000 people worldwide, IBA currently has installed systems across Europe and the US and is expanding into emerging markets. 

The Company is focused on providing solutions in the fight against cancer.